Transmedics Group Overview
Latest P/E ratio for Transmedics Group: 20.04 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow20.04
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Transmedics Group (TMDX) currently reports a P/E ratio of 20.04. That is below the Healthcare sector average of 25.93. Use the charts on this page to explore Transmedics Group's P/E ratio history and peer comparisons.
Transmedics Group's P/E ratio of 20.04 is lower than the Healthcare sector average of 25.93. That is roughly 22.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Transmedics Group's market price to a fundamental measure such as earnings, sales, or book value. At 20.04, TMDX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 20.04, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.93. From there, open related valuation or income-statement pages for Transmedics Group, and consider following TMDX for alerts when major investors trade the stock.
Transmedics Group is classified in the Healthcare sector. On P/E ratio, it currently shows 20.04 versus a sector average near 25.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TMDX with unrelated industries.
